Novavax, Inc. (NVAX) stock analysis
NVAX · Novavax, Inc.
Latest recorded price: USD 8.06
Sector and industry: Healthcare · Biotechnology
A reliable intrinsic value could not be calculated for NVAX; the assessment relies on sector multiple comparisons. Fiscal 2025 figures: revenue growth -17.2%, free cash flow margin -22.3%. The model flags 1 risk signal for this company (1 high severity).